Israeli drug maker, Teva Pharmaceuticals Industries Ltd. (ADR) (NYSE: TEVA) announced on Thursday that it will slash about 5,000 jobs, mainly by the end of next year as part of its broader restructuring plan, aimed at narrowing its oversized business and streamlining operations. The Company intends to focus on fast growing generic drug business as [...]
Recent Comments